## NOC: Northrop Grumman Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -1.9% below STRENGTH zone (3.0-6.0%); PEG 3.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($548.93)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 1)

**1. Northrop Grumman to design electronic controls for launch systems on ballistic missile submarines**
- Source: Military Aerospace | 20260106T074041 | Somewhat-Bullish | Relevance: 100%
- Northrop Grumman has secured a $120 million contract from the U.S. Navy to provide long-lead materials for the Columbia Development Launcher Program (CDLP). This program supports the missile launch systems for future Columbia-class and UK Dreadnought-class nuclear ballistic missile submarines, which will carry Trident II D5 nuclear missiles. The contract emphasizes the development and production of launcher subsystem hardware, ensuring the reliability of these next-generation naval deterrents.

**2. Assessing Northrop Grumman (NOC) Valuation As Key Defense Programs Draw Renewed Attention**
- Source: Simply Wall Street | 20260105T183441 | Somewhat-Bullish | Relevance: 100%
- Northrop Grumman (NOC) is gaining significant attention due to its involvement in key Pentagon programs, prompting an assessment of its valuation. While a popular narrative suggests an 11.6% undervaluation with a fair value of $662.68 due to robust defense cash flows and program ramps, a Discounted Cash Flow (DCF) model indicates potential overvaluation at a fair value of $512.83 against its current share price of $585.66. The article encourages investors to consider both perspectives and conduct their own research into the company's financial health, risks, and growth prospects.

**3. Northrop Grumman wins $94.3 million Navy contract for rocket motors By Investing.com**
- Source: Investing.com UK | 20260107T150959 | Bullish | Relevance: 100%
- Northrop Grumman has secured a $94.3 million contract from the U.S. Navy to develop a new 21-inch diameter second-stage solid rocket motor. This motor is designed to counter advanced aerial and hypersonic threats and will support various missions including air warfare and ballistic missile defense. The contract includes initial design and production of 60 units, with work to be performed at Northrop Grummanâ€™s Propulsion Innovation Center in Maryland.

**4. Morgan Stanley says buy these defense stocks post Venezuela and Iran**
- Source: CNBC | 20260106T195504 | Bullish | Relevance: 89%
- Morgan Stanley suggests buying defense stocks due to rising geopolitical tensions, particularly after recent U.S. military actions in Venezuela and Iran. Despite trading at a discount, the sector is expected to benefit from increased military spending, especially in areas like 3D printing for drone manufacturing. Northrop Grumman is highlighted as the top pick, with RTX, L3Harris Technologies, and General Dynamics also favored.

**5. Defense ETFs to Gain if Trump Acts on His Intervention Threat on Iran**
- Source: The Globe and Mail | 20260107T151118 | Bullish | Relevance: 87%
- The global security landscape has become volatile following threats of military intervention in Iran by Donald Trump amidst ongoing protests. This potential conflict could lead to increased military spending and procurement, benefiting major defense contractors like Lockheed Martin, Northrop Grumman, and RTX Corp. Investors looking to capitalize on these geopolitical tensions may consider prominent defense exchange-traded funds (ETFs) such as iShares U.S. Aerospace & Defense ETF (ITA), Global X Defense Tech ETF (SHLD), and Invesco Aerospace & Defense ETF (PPA) as a diversified investment strategy.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Morgan Stanley | $714 | $720 | -1% |
| 2025-12-15 | Alembic Global | $662 | $0 | 0% |
| 2025-12-12 | Citigroup | $654 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Morgan Stanley | main | Overweight |
| 2025-12-15 | Alembic Global | up | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.5% (+0.8%)
- State Street Corpora: 9.3% (-1.6%)
- Capital Internationa: 8.2% (-1.7%)
- Blackrock Inc.: 6.9% (+1.0%)
- JPMORGAN CHASE & CO: 3.9% (+91.5%)

### Key Risks

1. Valuation stretched: PEG 3.7x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.69 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Balance sheet: $1.3B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $82.6B |
| Beta | 0.05 |
| 52W Range | $426.24 - $640.90 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.69 |
| Forward P/E | 20.0 |
| Current P/E | 22.1 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.2% to -1.9% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.9pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.56), confirming momentum. RSI neutral at 50. OFD pattern: -FTH (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.86% (CS: 23) | Neutral |
| RSI_14 | 50.0 | Neutral |
| MACD Histogram | 2.56 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 1.011x | Above |
| vs SMA200 | 1.055x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $576.69
- **Stop Loss:** $548.93 (4.8% risk)
- **Target:** $604.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 27
- **Position Value:** $15,570.63
- **Portfolio %:** 15.57%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-01-29 (Est: $6.95)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.46 | $7.67 | +18.8% |
| 2025Q2 | $6.80 | $8.15 | +19.9% |
| 2025Q1 | $6.26 | $3.32 | -47.0% |
| 2024Q4 | $6.35 | $6.39 | +0.7% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_10*